Vaccines critical for controlling chronic diseases

Vaccines are a vital part of controlling non-communicable diseases (NCDs) around the world, even though most shots are designed to prevent illnesses that can be passed from person-to-person. That's according to health experts who spoke at a recent U.N. General Assembly summit on NCDs.

"A number of what we call NCDs turn out to be infectious diseases. About 20% of cancer is actually caused by infectious agents.  We've had a lot of success getting rid of hepatitis B, which is the largest cause of liver cancer and we are hoping with the...[HPV vaccine] to be able to get rid of cervical cancer," noted GAVI Alliance CEO Seth Berkley. Increased vaccine access worldwide is one way to prevent many NCDs, but other risk factors--like obesity, heart conditions, diabetes and many cancers--will have to be dealt with in other ways.

- read the article for more

PLUS: Every year more than 2 million kids die before the age of 5 due to vaccine-preventable diseases. In an effort to further protect children from preventable diseases (and, in the long run, NCDs) the GAVI Alliance announced this week it would commit $3.4 billion over the next four years for rotavirus and pneumonia vaccines for children in 37 developing countries. Of the countries targeted by the funding, two dozen are in Africa. News

Suggested Articles

Former FDA Commissioner Scott Gottlieb says 40% of the population needs to be vaccinated to achieve COVID-19 herd immunity.

CanSino Bio, Moderna and a collaboration between Oxford Univeristy and AstraZeneca are frontrunners, but they all face hurdles shared and unique.

Merck & Co. inked a series of deals to advance three COVID-19 projects, trailing some of its large pharma peers into the industrywide research effort.